Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
ZNF408 has emerged as a significant contributor to familial exudative vitreoretinopathy (FEVR), with multiple independent case reports and multi‐patient studies providing compelling genetic and functional evidence. Studies have identified several missense variants, including the recurrent variant c.1363C>T (p.His455Tyr) (PMID:23716654), that segregate with the disease phenotype in families across different populations. The genetic findings are further supported by segregation data in affected relatives, with at least 19 additional family members demonstrating co‐segregation of pathogenic variants with clinical features of FEVR (PMID:32530348). These observations have bolstered the overall clinical validity of ZNF408 as a disease gene, placing its gene–disease association in the Strong category. The cumulative data from these studies has reduced the uncertainty surrounding variant pathogenicity in ZNF408, aiding in refining clinical diagnosis and risk prediction. In addition, the consistent identification of pathogenic variants across unrelated probands reinforces the reproducibility of the association.
Genetic evidence for ZNF408 centers on its association with autosomal dominant transmission of FEVR. Case reports describe multiple families in which heterozygous variants are identified and shown to segregate with the characteristic retinal vascular abnormalities. Detailed variant analyses have revealed a spectrum that includes missense changes as well as potential loss‐of‐function events, with c.1363C>T (p.His455Tyr) being illustrative of the molecular defect. In silico predictions and segregation analyses in these studies further confirm the deleterious nature of the identified variants (PMID:27316669). The variant spectrum observed is diverse yet functionally convergent, supporting a causative role for ZNF408. This evidence has contributed to assigning a high ClinGen tier to the genetic evidence for ZNF408 in FEVR.
Functional studies provide critical mechanistic insights into the role of ZNF408 in retinal vasculogenesis. Experiments, including immunolocalization in COS‐1 cells and zebrafish knockdown models, have demonstrated that mutant ZNF408 protein exhibits mislocalization and exerts a dominant‐negative effect on its wild‐type counterpart (PMID:23716654). These functional assays show that aberrant ZNF408 disrupts normal nuclear functions and impairs the transcriptional regulation of vascular development genes. Rescue experiments in animal models have further confirmed that the mutant protein fails to support normal vessel formation, thereby replicating key features of FEVR. Such experimental concordance provides a solid basis for understanding the pathogenic mechanism underlying the observed clinical phenotype. Consequently, these data have been instrumental in elevating the functional evidence to a Moderate ClinGen tier.
The integration of robust genetic and experimental findings provides a cohesive narrative for the role of ZNF408 in FEVR. Multiple reports have documented the consistent identification of pathogenic variants that segregate with disease across distinct ethnic cohorts, while animal and cell‐based models substantiate the deleterious effect of mutant ZNF408 on retinal vascular development. Together, these studies support a mechanism of dominant‐negative interference, explaining the autosomal dominant inheritance pattern observed in affected families. Despite some variability in expressivity and the occasional overlap with other retinal disorders, the preponderance of evidence firmly supports ZNF408 as a causative gene in FEVR. Importantly, these insights facilitate more accurate diagnostic decision‑making and the development of targeted genetic testing panels. Moreover, ongoing research continues to expand the mutation spectrum and refine the clinical criteria for affected patients.
Further support for this association is provided by multi‑patient studies that have sequenced large cohorts of FEVR probands. These studies, performed using next‑generation sequencing and detailed segregation analyses, have demonstrated that while ZNF408 variants are less frequent compared to other FEVR‐associated genes, their identification is consistent and reproducible. The data, which include both novel and recurrent variants, ensure that the genetic contribution of ZNF408 is not an isolated finding but rather part of the broader genetic architecture of FEVR. This wealth of evidence exceeds the minimal criteria required by ClinGen scoring and reinforces the translational relevance of ZNF408 in clinical settings. As a result, genetic testing for ZNF408 mutations is increasingly being adopted in diagnostic laboratories. This integration of genetic and experimental data drives forward both clinical and commercial applications in the management of FEVR.
In summary, the association between ZNF408 and exudative vitreoretinopathy is supported by strong genetic evidence from multiple independent families combined with experimentally validated functional impairments. The autosomal dominant inheritance, delineated variant spectrum—including the well‐characterized c.1363C>T (p.His455Tyr) change—and corroborative in vivo and in vitro studies converge to underscore the gene’s pathogenic role. This comprehensive evidence base not only informs diagnostic decision‑making and risk assessment but also paves the way for future targeted therapeutic strategies. Key take‑home message: Incorporation of ZNF408 genetic testing in patients with FEVR can significantly enhance diagnostic accuracy and guide tailored clinical management.
Gene–Disease AssociationStrongMultiple independent studies report pathogenic ZNF408 variants in several probands with FEVR, with robust segregation data and experimental evidence supporting a dominant-negative mechanism (PMID:23716654, PMID:32530348). Genetic EvidenceStrongThe association is supported by a diverse array of variant types identified in unrelated families, including the recurrent c.1363C>T (p.His455Tyr) variant, with consistent segregation across affected relatives and confirmation in large cohorts (PMID:27316669). Functional EvidenceModerateFunctional assays in cellular and zebrafish models demonstrate that mutant ZNF408 causes mislocalization and exerts a dominant-negative effect, leading to impaired retinal vasculogenesis (PMID:23716654). |